Source comparison
Best Tesamorelin + Ipamorelin Blend Dosage: Research Comparison
Conservative Titration 0.3mg 0.2mg 0.5mg 60/40 140–180% over baseline Initial tolerance phase, elderly populations, first-time users Appropriate starting point. Minimal side effects but subtherapeutic for sustained research Standard Research Protocol 0.9mg 0.6
This comparison does not assign a generated winner or score.
- Conservative Titration
- 0.3mg
- 0.2mg
- 0.5mg
- 60/40
- 140–180% over baseline
- Initial tolerance phase, elderly populations, first-time users
- Appropriate starting point. Minimal side effects but subtherapeutic for sustained research
- Standard Research Protocol
- 0.9mg
- 0.6mg
- 1.5mg
- 350–400% over baseline
- Most phase II trials, metabolic research, body composition studies
- Optimal balance of efficacy and tolerability for most applications
- High-Output Protocol
- 1.2mg
- 0.8mg
- 2.0mg
- 420–480% over baseline
- Performance research, IGF-1 pathway studies, anabolic signalling
- Maximum GH output without entering diminishing returns zone
- Balanced Pulse Extension
- 0.75mg
- 50/50
- 320–360% over baseline
- Circadian rhythm studies, sleep-stage GH research
- Lower peak but extended duration. Useful for sustained exposure models
- Aggressive GHRH Bias
- 1.4mg
- 70/30
- 440–500% over baseline
- Acute secretion studies, pituitary response research
- Higher side effect incidence (flushing, joint stiffness) limits practical use